Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy. (2022)

First Author: Morelli T
Attributed to:  Bioengineering to combat the tuberculosis pandemic funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1136/thoraxjnl-2021-217260

PubMed Identifier: 34607905

Publication URI: http://europepmc.org/abstract/MED/34607905

Type: Journal Article/Review

Volume: 77

Parent Publication: Thorax

Issue: 3

ISSN: 0040-6376